ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC15194-10mg |
|
1292799-56-4 |
PF-2545920
|
0 | C25H20N4O | |
GC15192-50mg |
|
280749-17-9 |
A 286982
|
0 | C24H27N3O4S | |
GC15192-10mg |
|
280749-17-9 |
A 286982
|
0 | C24H27N3O4S | |
GC15190-10mM (in 1mL DMSO) |
|
896705-16-1 |
BMH-21
|
0 | C21H20N4O2 | |
GC15190-200mg |
|
896705-16-1 |
BMH-21
|
0 | C21H20N4O2 | |
GC15190-50mg |
|
896705-16-1 |
BMH-21
|
0 | C21H20N4O2 | |
GC15190-10mg |
|
896705-16-1 |
BMH-21
|
0 | C21H20N4O2 | |
GC15189-50mg |
|
334827-98-4 |
Gisadenafil besylate
|
0 | C23H33N7O5S.C6H6O3S | |
GC15189-10mg |
|
334827-98-4 |
Gisadenafil besylate
|
0 | C23H33N7O5S.C6H6O3S | |
GC15188-500μg |
|
235082-52-7 |
MEN 11270
|
0 | C60H90N20O11S | |
GC15187-10mM (in 1mL DMSO) |
|
1195765-45-7 |
Dabrafenib (GSK2118436)
|
0 | C23H20F3N5O2S2 | |
GC15187-100mg |
|
1195765-45-7 |
Dabrafenib (GSK2118436)
|
0 | C23H20F3N5O2S2 | |
GC15187-50mg |
|
1195765-45-7 |
Dabrafenib (GSK2118436)
|
0 | C23H20F3N5O2S2 | |
GC15187-10mg |
|
1195765-45-7 |
Dabrafenib (GSK2118436)
|
0 | C23H20F3N5O2S2 | |
GC15186-10mM (in 1mL DMSO) |
|
94-16-6 |
Sodium 4-amiropparaty Hyalrate
|
0 | C9H9N2NaO3 | |
GC15186-1g |
|
94-16-6 |
Sodium 4-amiropparaty Hyalrate
|
0 | C9H9N2NaO3 | |
GC15186-50mg |
|
94-16-6 |
Sodium 4-amiropparaty Hyalrate
|
0 | C9H9N2NaO3 | |
GC15185-10mM (in 1mL DMSO) |
|
56-75-7 |
Chloramphenicol
|
0 | C11H12Cl2N2O5 | |
GC15185-50mg |
|
56-75-7 |
Chloramphenicol
|
0 | C11H12Cl2N2O5 | |
GC15184-10mM (in 1mL DMSO) |
|
107-35-7 |
Taurine
|
0 | C2H7NO3S | |